Given that recent studies revealed that PRELP interacts with several growth factors including transforming growth factor β1 (TGFβ1) involved in signal transduction in cancer11,13, PRELP is expected to suppress tumor cell growth triggered by the multi-specific ligand binding. The gene discussed is PRELP; the disease is neoplasm.